These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6461331)

  • 21. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propionibacterium acnes osteomyelitis occurring 23 years after craniotomy: case report and review of literature.
    Levitt MR; Gabikian P; Pottinger PS; Silbergeld DL
    Neurosurgery; 2011 Sep; 69(3):E773-9; discussion E779. PubMed ID: 21471838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
    Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
    Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients. Investigations on juvenile acne patients with predominant comedones and healthy controls (author's transl)].
    Gloor M; Lamerz A; Höffler U; Franke M
    Dermatol Monatsschr; 1980 Dec; 166(12):798-803. PubMed ID: 6452296
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of culture and PCR methods for identifying
    Naghdi N; Ghane M
    Turk J Med Sci; 2017 Jun; 47(3):967-972. PubMed ID: 28618752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propionibacterium acnes vertebral osteomyelitis: seek and ye shall find?
    Kowalski TJ; Berbari EF; Huddleston PM; Steckelberg JM; Osmon DR
    Clin Orthop Relat Res; 2007 Aug; 461():25-30. PubMed ID: 17483730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
    Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
    Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
    Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acne vulgaris and malignancy.
    Sheehan-Dare RA; Cunliffe WJ; Simmons AV; Child JA; McKinney PA; Cartwright RA
    Br J Dermatol; 1988 Nov; 119(5):669-73. PubMed ID: 2974720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.